BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29413418)

  • 1. DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.
    Putzbach W; Gao QQ; Patel M; Haluck-Kangas A; Murmann AE; Peter ME
    Trends Cancer; 2018 Jan; 4(1):10-19. PubMed ID: 29413418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The siRNA Non-seed Region and Its Target Sequences Are Auxiliary Determinants of Off-Target Effects.
    Kamola PJ; Nakano Y; Takahashi T; Wilson PA; Ui-Tei K
    PLoS Comput Biol; 2015 Dec; 11(12):e1004656. PubMed ID: 26657993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of DISE-inducing shRNAs by monitoring cellular responses.
    Patel M; Peter ME
    Cell Cycle; 2018; 17(4):506-514. PubMed ID: 29092660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity.
    Vaidyanathan A; Taylor HE; Hope TJ; D'Aquila RT; Bartom ET; Hultquist JF; Peter ME
    J Virol; 2023 Jul; 97(7):e0065223. PubMed ID: 37310263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells.
    Li C; Liu Z; Yang F; Liu W; Wang D; Dong E; Wang Y; Wu CI; Lu X
    Oncotarget; 2015 Aug; 6(25):21603-13. PubMed ID: 26057633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD95/Fas ligand mRNA is toxic to cells.
    Putzbach W; Haluck-Kangas A; Gao QQ; Sarshad AA; Bartom ET; Stults A; Qadir AS; Hafner M; Peter ME
    Elife; 2018 Oct; 7():. PubMed ID: 30324908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential cleavage of upstream targets in concatenated miRNA/siRNA target sites support a 5'-3' scanning model for RISC target recognition.
    Zhang M; Zhang C
    Biochem Biophys Res Commun; 2024 Apr; 703():149662. PubMed ID: 38359613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID.
    Kamiya Y; Takeyama Y; Mizuno T; Satoh F; Asanuma H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
    Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
    Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.
    Kim K; Lee YS; Carthew RW
    RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
    Naito Y; Yoshimura J; Morishita S; Ui-Tei K
    BMC Bioinformatics; 2009 Nov; 10():392. PubMed ID: 19948054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect.
    Ui-Tei K; Naito Y; Zenno S; Nishi K; Yamato K; Takahashi F; Juni A; Saigo K
    Nucleic Acids Res; 2008 Apr; 36(7):2136-51. PubMed ID: 18267968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress of RNA interference mechanism].
    Yan F; Cheng ZM
    Yi Chuan; 2005 Jan; 27(1):167-72. PubMed ID: 15730978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the siRNA passenger strand during RISC assembly in human cells.
    Leuschner PJ; Ameres SL; Kueng S; Martinez J
    EMBO Rep; 2006 Mar; 7(3):314-20. PubMed ID: 16439995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Molecule Analysis of the Target Cleavage Reaction by the Drosophila RNAi Enzyme Complex.
    Yao C; Sasaki HM; Ueda T; Tomari Y; Tadakuma H
    Mol Cell; 2015 Jul; 59(1):125-32. PubMed ID: 26140368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focusing on RISC assembly in mammalian cells.
    Hong J; Wei N; Chalk A; Wang J; Song Y; Yi F; Qiao RP; Sonnhammer EL; Wahlestedt C; Liang Z; Du Q
    Biochem Biophys Res Commun; 2008 Apr; 368(3):703-8. PubMed ID: 18252196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.